 |
|
Abnormal Results of Dexamethasone Suppression Tests in Nondepressed Patients With Diabetes Mellitus
James I. Hudson, MD;
Margo S. Hudson, MD;
Anthony J. Rothschild, MD;
Louis Vignati, MD;
Alan F. Schatzberg, MD;
James C. Melby, MD
Arch Gen Psychiatry. 1984;41(11):1086-1089.
Abstract
• To investigate the specificity of the dexamethasone suppression test (DST) for the diagnosis of major depression in patients with diabetes mellitus, we administered 1 mg of dexamethasone to 30 nondepressed diabetics and to 58 normal controls at 11 PM. Diabetic subjects received hemoglobin A, (Hb A,) determinations, the Hamilton Rating Scale for Depression (HRSD), and five to eight blood glucose determinations during the 48 hours surrounding the DST. Results demonstrated a significantly higher rate of nonsuppression (plasma cortisol level,  5 µg/dL) at 4 PM the following day among diabetics (43%) than among controls (7%) but no difference between these groups in the rate of nonsuppression at 8 AM. Plasma cortisol level at 4 PM correlated with Hb A1 level but not with duration of illness, HRSD score, mean blood glucose level, or maximum blood glucose excursion. These results suggest that the results of the DST used as a diagnostic test for major depression must be interpreted with caution in patients with diabetes.
Author Affiliations
From the Department of Psychiatry, Harvard Medical School, Boston (Drs J. I. Hudson, Rothschild, and Schatzberg); McLean Hospital, Boston (Drs J. I. Hudson, Rothschild, and Schatzberg); Joslin Clinic, New England Deaconess Hospital, Boston (Drs M. S. Hudson and Vignati); and the Section of Endocrinology and Metabolism, Evans Department of Clinical Research and Department of Medicine, Boston University School of Medicine and Hospital (Dr Melby).
Footnotes
Accepted for publication Jan 27, 1984.
Reprint requests to Mailman Research Center, McLean Hospital, Belmont, MA 02178 (Dr J. I. Hudson).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Elevated Fasting Plasma Cortisol Is Associated with Ischemic Heart Disease and Its Risk Factors in People with Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
Reynolds et al.
J. Clin. Endocrinol. Metab. 2010;95:1602-1608.
ABSTRACT
| FULL TEXT
Cortisol Secretion in Patients With Type 2 Diabetes: Relationship with chronic complications
Chiodini et al.
Diabetes Care 2007;30:83-88.
ABSTRACT
| FULL TEXT
Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats
Inouye et al.
Am. J. Physiol. Endocrinol. Metab. 2002;282:E1369-E1379.
ABSTRACT
| FULL TEXT
Hyperactivation of the Hypothalamo-Pituitary-Adrenocortical Axis in Streptozotocin-Diabetes Is Associated with Reduced Stress Responsiveness and Decreased Pituitary and Adrenal Sensitivity
Chan et al.
Endocrinology 2002;143:1761-1768.
ABSTRACT
| FULL TEXT
Molecular Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Streptozotocin-Induced Diabetes: Effects of Insulin Treatment
Chan et al.
Endocrinology 2001;142:4872-4879.
ABSTRACT
| FULL TEXT
Supraphysiological Hyperinsulinemia Acutely Increases Hypothalamic-Pituitary-Adrenal Secretory Activity in Humans
Fruehwald-Schultes et al.
J. Clin. Endocrinol. Metab. 1999;84:3041-3046.
ABSTRACT
| FULL TEXT
The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana et al.
Arch Gen Psychiatry 1985;42:1193-1204.
ABSTRACT
Hypothalamic-Pituitary-Adrenocortical Activity in Patients With Diabetes Mellitus
Cameron et al.
Arch Gen Psychiatry 1984;41:1090-1095.
ABSTRACT
|
